Nicotine Patch - Bioequivalence Study

The purpose of this study is to evaluate the bioequivalence of a new transdermal nicotine patch to that of a reference formulation following repeated applications

Lead sponsor: Pierre Fabre Medicament•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

WITHDRAWN

Biomarkers of iNOS Activity in COPD, Asthma, Healthy Control

NCT00159302 · Healthy Smokers, Healthy Non-smokers, and more

COMPLETED

Efficacy and Safety of an Electronic Nicotine Delivery Device (E-Cigarette)

NCT01164072 · Healthy Smokers, Smoking Cessation

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 12, 2014Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment74

Start dateMar 2014

Last updatedJun 12, 2014

Condition

Healthy Smokers

Locations shown

Gières

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 12, 2014Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions